Nevertheless, it is of interest to explore the effect of TNFR2-PLGA treatment in mouse tumor models in subsequent study to examine if the potential of anti-TNFR2 antibody grafted on nanoparticles would exhibit greater potency in enhancing cancer-targeted delivery and promoting antitumor immune responses. Here, TNFRSF1B is linked to neoplasm.